Social Media Content Creators Driving Parallel Trade for Unapproved Slimming Drug
An underground market for unapproved weight-loss drugs is being driven by social media fitness personalities and vendors on communication apps, based on new investigations.
Investigational Drug Acquiring Traction Online
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Followers are urged to contact these profiles privately for source information, while also obtaining discount codes.
Active Commerce on Messaging Platforms
Additionally, a robust market exists on messaging services, where communities with thousands of participants share “before and after” images, administration instructions and assertions of next-day British shipping. Vendors market the substance there before directing customers to other platforms for transactions.
Understanding The Experimental Drug
This medication is an experimental injectable created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.
Healthcare Professionals Express Concerns
Nevertheless, doctors and pharmacists have warned that the sale of what remains an unapproved medication in the UK is worrisome and could lead to users injecting products of uncertain source.
Some professionals said the demand for the experimental drug could be connected to the rising price of approved slimming products such as Mounjaro.
Legal Status and Implementation
Marketing the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unapproved drug that cannot be promoted or supplied for personal consumption under the British medical regulations.
Several content creators try to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still violate medicines, advertising, and consumer laws, potentially leading to fines, legal action or imprisonment.
Service Reaction and Material Elimination
According to TikTok, the service has removed problematic content and banned related hashtags and query recommendations. The company said it was dedicated to maintaining the service secure and allocating resources in strengthening enforcement strategies.
Digital Marketplace Activities
Research also found groups with up to 9,000 members selling the experimental drug using Telegram's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately displays groups with numerous of users, filled with images of slimming results, glowing testimonials and step-by-step instructions for mixing or administering at home.
After minutes of entering one group, a seller shared contact information, where most transactions take place. The seller provided an guidebook and guaranteed delivery within 48 hours. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one asked about weight, health issues or past usage.
Item Information and Pricing
Within these groups, messages display dark colored packages with Royal Mail labels, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at home with sterile water, or ready-to-use pens typically priced at £160 for 20mg. When asked how much time a injector should be used, sellers give conflicting answers ranging from a several days to “depends on your body”.
Service Oversight and Safety Actions
A spokesperson for Telegram said it actively monitored harmful content on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“People are administering materials they cannot confirm. Although the research behind this drug is sound, these online versions may not contain what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to current cost increases for approved weight-loss drugs such as Mounjaro. “With prices increasing, patients are using social media. But counterfeit treatments are extremely dangerous. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she said.
Her team has previously seen patients injured by self-injection from unverified suppliers. “We understand the disappointment, but purchasing from messaging apps or communication platforms is gambling with your health,” said the doctor. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Statement
A representative from the pharmaceutical company stated the substance was in third stage research studies and had not been reviewed or approved by any regulatory agency globally. “Therefore at this time no one can sell [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company investigational substance not yet approved … may subject patients to possibly significant health risks”.